Indonesia · Delayed Price · Currency is IDR IDX:LABS Statistics
Total Valuation
IDX:LABS has a market cap or net worth of IDR 643.85 billion. The enterprise value is 660.74 billion.
| Market Cap | 643.85B |
| Enterprise Value | 660.74B |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:LABS has 3.95 billion shares outstanding.
| Current Share Class | 3.95B |
| Shares Outstanding | 3.95B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.87% |
| Owned by Institutions (%) | n/a |
| Float | 700.57M |
Valuation Ratios
The trailing PE ratio is 60.23.
| PE Ratio | 60.23 |
| Forward PE | n/a |
| PS Ratio | 3.10 |
| PB Ratio | 4.11 |
| P/TBV Ratio | 4.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 47.79 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 61.81 |
| EV / Sales | 3.18 |
| EV / EBITDA | 20.30 |
| EV / EBIT | 31.95 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.15.
| Current Ratio | 2.80 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.73 |
| Debt / FCF | -5.21 |
| Interest Coverage | 17.07 |
Financial Efficiency
Return on equity (ROE) is 7.07% and return on invested capital (ROIC) is 8.98%.
| Return on Equity (ROE) | 7.07% |
| Return on Assets (ROA) | 5.98% |
| Return on Invested Capital (ROIC) | 8.98% |
| Return on Capital Employed (ROCE) | 12.99% |
| Weighted Average Cost of Capital (WACC) | 3.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 54 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, IDX:LABS has paid 4.02 billion in taxes.
| Income Tax | 4.02B |
| Effective Tax Rate | 27.31% |
Stock Price Statistics
The stock price has increased by +16.43% in the last 52 weeks. The beta is -0.21, so IDX:LABS's price volatility has been lower than the market average.
| Beta (5Y) | -0.21 |
| 52-Week Price Change | +16.43% |
| 50-Day Moving Average | 152.40 |
| 200-Day Moving Average | 148.29 |
| Relative Strength Index (RSI) | 53.31 |
| Average Volume (20 Days) | 2,661,925 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:LABS had revenue of IDR 207.82 billion and earned 10.69 billion in profits. Earnings per share was 2.71.
| Revenue | 207.82B |
| Gross Profit | 85.10B |
| Operating Income | 20.68B |
| Pretax Income | 14.71B |
| Net Income | 10.69B |
| EBITDA | 32.17B |
| EBIT | 20.68B |
| Earnings Per Share (EPS) | 2.71 |
Balance Sheet
The company has 6.86 billion in cash and 23.75 billion in debt, with a net cash position of -16.89 billion or -4.28 per share.
| Cash & Cash Equivalents | 6.86B |
| Total Debt | 23.75B |
| Net Cash | -16.89B |
| Net Cash Per Share | -4.28 |
| Equity (Book Value) | 156.70B |
| Book Value Per Share | 39.67 |
| Working Capital | 115.45B |
Cash Flow
In the last 12 months, operating cash flow was 13.47 billion and capital expenditures -18.03 billion, giving a free cash flow of -4.56 billion.
| Operating Cash Flow | 13.47B |
| Capital Expenditures | -18.03B |
| Depreciation & Amortization | 11.49B |
| Net Borrowing | -5.68B |
| Free Cash Flow | -4.56B |
| FCF Per Share | -1.15 |
Margins
Gross margin is 40.95%, with operating and profit margins of 9.95% and 5.14%.
| Gross Margin | 40.95% |
| Operating Margin | 9.95% |
| Pretax Margin | 7.08% |
| Profit Margin | 5.14% |
| EBITDA Margin | 15.48% |
| EBIT Margin | 9.95% |
| FCF Margin | n/a |
Dividends & Yields
IDX:LABS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.66% |
| FCF Yield | -0.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:LABS has an Altman Z-Score of 7.13 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.13 |
| Piotroski F-Score | 6 |